Evidence map›Paper›PMID 33682450›Full record

ArticleAnnals of the Royal College of Surgeons of England2021

Microvascular reconstruction for head and neck cancers in high risk population: clinical outcomes and complications.

R Katna, S Singh, B Bhosale, A Deshpande, N Kalyani, Mumbai Oncology Group – Head and Neck

Open access · greenAbstract read
In one paragraph

Article in Annals of the Royal College of Surgeons of England, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

R KatnaJaslok Hospital and Research Centre, Mumbai, India.
S SinghVedant Hospital, Thane, India.
B BhosaleJaslok Hospital and Research Centre, Mumbai, India.
A DeshpandeJaslok Hospital and Research Centre, Mumbai, India.
N KalyaniJaslok Hospital and Research Centre, Mumbai, India.
Mumbai Oncology Group – Head and Neck
Bhaktivedanta Hospital & Research Institute · INJaslok Hospital · INBombay Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMicrovascular reconstruction is the gold standard for reconstruction in oral cavity cancers. Age and comorbidities determine the type of reconstruction. We aimed to analyse the impact of high-risk comorbidities on perioperative morbidity.

methodsThis is a retrospective study of 317 patients undergoing microvascular reconstruction from January 2014 to December 2017. High risk patients were based on age, American Society of Anaesthesiologists (ASA) grade (III/IV) and Charlson comorbidity index (CCI) score >4; overall, 73 out of 317 patients were evaluated.

resultsMedian age was 59 years. Five patients (6.8%) had complete flap failures and seven (9.5%) had minor complications (wound breakdown, bleeding, wound dehiscence, partial flap loss). ASA score of IV was significantly associated with morbidity while age >65 years and CCI >4 was not associated. The overall flap success rate was 93.2%.

conclusionsA high-risk population has nearly similar outcomes for microvascular reconstruction as a younger age group. High ASA score adversely affects surgery-related outcomes.

Indexed as

AdultAgedAged, 80 and overFemaleHead and Neck NeoplasmsHumansMaleMicrosurgeryMiddle AgedPlastic Surgery ProceduresPostoperative ComplicationsRetrospective StudiesRisk FactorsSeverity of Illness IndexSquamous Cell Carcinoma of Head and NeckSurgical FlapsASACCIHead neck cancersMicrovascular reconstructionOral cavity

Identifiers

PMID33682450
PMCPMC10334729
OpenAlexW3134330819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.